🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Service Response and Content Removal

Based on the social media company, the service has removed problematic content and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found communities with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence.

Within moments of joining one community, a seller shared WhatsApp details, where most purchases occur. The vendor sent an guidebook and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Information and Costs

Inside these communities, messages show dark colored parcels with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has already seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to potentially significant health risks”.